06.10.2020 Views

YSM Issue 93.2

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

NANOMOLDED

INTO PERFECTION

SCIENTISTS DISCOVER NOVEL WAY

TO PRODUCE NANOMATERIALS

BY ATHENA STENOR

ILLUSTRATION COURTESY OF ELLI E GABRIEL

Increasingly today, nanotechnology is coming into our lives,

allowing us to design more efficient batteries, build lightweight

vehicles, and even administer needleless vaccines. However, a

major barrier to accessing the full potential of nanoscale materials

is their fabrication. A team of researchers from Yale University and

Wuhan University recently discovered that thermomechanical

nanomolding is a reliable method for the nanofabrication of

ordered phases (OPs).

OPs, a class of materials consisting of sublattices occupied by

atoms, are fundamental to various functional applications. Most

functional materials, including superconductors, magnetic materials

and plasmonic materials, belong to this class. Creating nanoscale

OPs is challenging because traditional techniques, such as chemical

vapor deposition growth, are not practical. For example, chemical

vapor deposition growth, a technique in which a film of vaporized,

decomposing chemical is deposited onto a substrate’s surface, only

works for easily vaporized OPs and cannot produce certain shapes.

But thermomechanical nanomolding can be scaled up for mass

production, fine-tuned to obtain specific characteristics, and used

with a variety of starting materials. In this technique, raw material was

pushed into a nanomold at steady pressure and a temperature below

its melting point, to produce single-crystalline nanowires of consistent

composition and structure. The process could be tuned so that the

nanowires’ aspect ratios were high, enabling easier access to different

morphologies. The researchers attribute their results to OPs’ tendency

to self-organize via a thermodynamic (stability-driven) rather than

kinetic (speed-driven) mechanism. This new process will make OPs a

more accessible class of nanomaterials, and enable the development of

exciting new applications for nanotechnology. ■

Liu, N., Xie., Y., Liu, G., Sohn, S., Raj, A., Han, G., Wu, B., Cha,

J.J., Liu, Z., & Schroers, J. (2020). General Nanomolding of

Ordered Phases. Physical Review Letters, 124(3). https://doi.

org/10.1103/physrevlett.124.036102

IMPLICATIONS

OF IMPELLA

RETHINKING TREATMENTS FOR

CARDIOGENIC SCHOCK

BY MIA JACKSON

ILLUSTRATION COURTESY OF NOORA SAID

More than one million Americans have a heart attack each

year. Four to twelve percent of these patients develop

cardiogenic shock, a condition that prevents one’s heart

from pumping the blood necessary to meet the body’s needs.

Two common treatments for cardiogenic shock include the

left ventricular assist device (LVAD) and the intra-aortic balloon

pump (IABP). While LVADs are more commonly used, Yale

University researchers recently reported the results of a study

examining the discrepancies in in-hospital clinical outcomes

between the two devices.

The study found that LVADs were associated with higher inhospital

mortality and in-hospital major bleeding. “Because there

is relatively little evidence in this area, we think that the analysis

that we did, and the conclusion that we made … would have

both policy implications and regulatory implications,” explained

Nihar Desai, an assistant professor at the Yale School of Medicine

who worked on this study.

Given the two-and-a-half-fold increase in the utilization of

LVADs between 2015 and 2017, Desai’s research suggests that

hospitals might need to rethink treatment plans for cardiogenic

shock. “We hope everyone is trying to integrate these data into

their practice, as it is on everyone to be a little more judicious of

[LVADs], given little evidence that would support their use,” Desai

said. Hopefully, this research will influence the way many doctors

treat cardiogenic shock patients. After all, for every patient that

enters the emergency room, the most common treatment option

available should be the best one for them. ■

Desai, N.R. (2020). Association of Use of an Intravascular

Microaxial Left Ventricular Assist Device vs Intra-aortic

Balloon Pump With In-Hospital Mortality and Major

Bleeding Among Patients With Acute Myocardial Infarction

Complicated by Cardiogenic Shock. JAMA, 323(8), 734–45.

https://doi.org/10.1001/jama.2020.0254

6 Yale Scientific Magazine September 2020 www.yalescientific.org

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!